Substance / Medication

Nifedipine

Overview

Active Ingredient
nifedipine
RxNorm CUI
7417
Labeler: Major PharmaceuticalsUpdated: 2026-02-19T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Known hypersensitivity reaction to nifedipine.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Risk of postpartum readmission following discharge on nifedipine or labetalol for hypertensive disorders of pregnancy: A systematic review and meta-analysis.
Kanninen Tomi, Ortiz Vanessa, Alvarez-Perez Jesus et al. · Eur J Obstet Gynecol Reprod Biol · 2025
PMID: 40914007Meta-Analysis
Magnesium sulfate versus nifedipine for tocolysis: meta-analysis of randomized controlled trials.
de Souza Amaxsell Thiago Barros, de Lima Machado Maria Letícia, Sarmento Ayane Cristine Alves et al. · Women Health · 2025
PMID: 39626700Meta-Analysis
Oral nifedipine versus intravenous labetalol for hypertensive emergencies during pregnancy: a systematic review and meta-analysis.
Li Lin, Xie Wenxia, Xu Hao et al. · J Matern Fetal Neonatal Med · 2023
PMID: 37487762Meta-Analysis
Oral nifedipine may be a preferential option for treating acute severe hypertension during pregnancy: a meta-analysis.
Ou Minghui, Zhang Futao, Cui Shichao et al. · Hypertens Pregnancy · 2023
PMID: 37434338Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Nifedipine (substance)
SNOMED CT
387490003
UMLS CUI
C0028066
RxNorm CUI
7417
Labeler
Major Pharmaceuticals

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.